TriSalus Life Sciences Inc. (TLSI) — Net Asset Quality Index
TriSalus Life Sciences Inc. (TLSI) has a Net Asset Quality Index of 10.5% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $62.45 Million minus total liabilities of $55.90 Million yields net assets of $6.55 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read TriSalus Life Sciences Inc. balance sheet liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
TriSalus Life Sciences Inc. Net Asset Quality Index Over Time (2021–2025)
This chart shows how TriSalus Life Sciences Inc.'s Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of June 2026, the index stands at 10.5%, representing net assets of $6.55 Million against total assets of $62.45 Million USD. For live market cap and overall valuation, see TriSalus Life Sciences Inc. market cap and net worth.
Annual Net Asset Quality Index for TriSalus Life Sciences Inc. (2021–2025)
The table below presents the year-by-year Net Asset Quality Index for TriSalus Life Sciences Inc. from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See TriSalus Life Sciences Inc. book value and equity for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -95.8% | $-33.86 Million | $35.33 Million | $69.19 Million | ▲ +12.2 pp |
| 2024 | -108.0% | $-25.89 Million | $23.97 Million | $49.87 Million | ▲ +2.0 pp |
| 2023 | -110.0% | $-27.07 Million | $24.60 Million | $51.66 Million | ▼ -54.0 pp |
| 2022 | -56.0% | $-12.32 Million | $22.00 Million | $34.32 Million | ▼ -137.7 pp |
| 2021 | 81.7% | $30.90 Million | $37.84 Million | $6.93 Million | — |